SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

iShares Silver Trust - Fractional undivided beneficial interests

iShares Silver Trust

iShares Silver Trust is seeing heightened activity as market participants closely track falling U.S. bond yields and a weakening dollar, which are fueling bullish sentiment for precious metals. Community discussions are heavily centered on a potential technical breakout, with many investors debating whether to accumulate physical holdings as a hedge against long-term fiat currency devaluation.

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. The company was founded by Carl Lars G. Hensen, Kathleen Lisaingo, Kevin Heyries, Véronique Lecault and Daniel Da Costa on November 8, 2012 and is headquartered in Vancouver, Canada.

AbCellera Biologics Inc

AbCellera Biologics is experiencing intense community focus and bullish momentum following positive Phase 2 clinical trial results for its drug candidate ABCL635, which exceeded efficacy and safety expectations. Investors are actively debating the company's transition from a discovery platform to a proprietary drug developer, with many viewing this de-risked asset as a potential validator for the company's broader AI-driven platform.

Archer Aviation, Inc. engages in the development of electric vertical take-off and landing (eVTOL) aircraft. The company was founded by Brett Adcock and Adam Goldstein on October 16, 2018, and is headquartered in San Jose, CA.

Archer Aviation Inc - Ordinary Shares - Class A

Archer Aviation Inc

Archer Aviation is capturing significant market attention following its acquisition of three Boeing subsidiariesWisk Aero, SkyGrid, and Insituwhich has brought in an established defense revenue stream and solidified Boeing as a major shareholder. Investors and community members are closely monitoring upcoming earnings and integration progress, while traders debate the stock's potential for a short squeeze against its high short interest.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride-share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company was founded by Peter Beck in 2006 and is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab is experiencing high volatility as investors position themselves ahead of the upcoming earnings release, with heavy community focus on Neutron launch timelines and potential growth in space systems contracts. While some investors remain cautious about pre-earnings price fluctuations and potential short-term pullbacks, the broader conversation centers on long-term conviction in the companys vertically integrated infrastructure and its expanding role in the space economy.

AXT, Inc. engages in the design, development, manufacture and distribution of compound and single element semiconductor substrates. It also sells specialty material substrates and raw materials used to make substrates and other related products. The company was founded by Morris S. Young and Davis Zhang in 1986 and is headquartered in Fremont, CA.

AXT Inc

AXT Inc. is trending following a massive post-earnings rally driven by record demand for indium phosphide substrates, a critical material used in AI optical connectivity. While the company is seeing strong institutional support and analyst upgrades, the community remains divided, with some investors betting on a continued squeeze toward higher price targets, while others express caution regarding the sustainability of the valuation and potential risks tied to China-based manufacturing.

RUM Group, Inc. engages in operating an online neutral video platform. It operates through the following geographical segments: United States, Canada, and Other. The company was founded in October 2013 by Chris Pavlovski and is headquartered in Longboat Key, FL.

RUM Group Inc. - Ordinary Shares - Class A

RUM Group Inc.

Rumble is trending as investors focus on the upcoming earnings report and the company's strategic pivot into AI infrastructure, fueled by its recent Northern Data acquisition, 22,000 GPU capacity, and high short interest that has sparked intense community discussion about a potential short squeeze. Traders are keenly awaiting formal financial guidance and updates on major cloud contracts, which many believe will act as a re-rating catalyst for the stock's valuation.

United States Antimony Corp. engages in the extraction, processing and sale of antimony, zeolite, silver, and gold products. It operates through the following segments: United States Antimony Operations, Mexican Antimony Operations, Precious Metals Recovery, and United States Zeolite Operations. The company was founded by John C. Lawrence in June 1968 and is headquartered in Dallas, TX.

United States Antimony Corp.

United States Antimony Corp. is trending as investors monitor the company's critical role in the U.S. defense supply chain and its ongoing government contract discussions. The community is actively debating the stock's potential for a short squeeze amidst significant institutional buying and expectations for a strong rebound in critical mineral demand.

Fastly, Inc. provides real-time content delivery network services. It offers edge compute, edge delivery, edge security, edge applications like load balancing and image optimization, video on demand, and managed edge delivery. The company was founded by Artur Bergman, Tyler McMullen, Simon Wistow, and Gil Penchina in March 2011 and is headquartered in San Francisco, CA.

Fastly Inc - Ordinary Shares - Class A

Fastly Inc

Fastly is experiencing heightened volatility following a drastic post-earnings sell-off that has triggered a intense debate among investors regarding whether the stock is an oversold opportunity or a broken growth story. While the community is actively tracking institutional accumulation, short interest, and the stock's role in the AI-edge computing sector, sentiment remains sharply divided between those calling for a rebound to previous highs and others bracing for further downside.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is trending as institutional ownership by major firms continues to surge, fueling community speculation about an imminent buyout or positive data readout from the REGAL trial. Investors are closely monitoring the upcoming 80th trial event, with many actively discussing the potential for a market-moving catalyst as the company approaches its next earnings report.

Select Sector SPDR Trust (The) - State Street Energy Select Sector SPDR ETF

Energy Select Sector SPDR Fund

The Energy Select Sector SPDR Fund (XLE) is under intense focus as investors weigh the impact of an emerging peace agreement between the U.S. and Iran, which has triggered volatility in crude oil markets and raised questions about the sustainability of current energy sector valuations. The community is actively debating the potential for a long-term supply shift, with some traders highlighting the critical nature of ongoing geopolitical tensions and low global inventories, while others speculate that the normalization of shipping traffic through the Strait of Hormuz could pressure oil-linked equities.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Cardlytics Second Quarter 2026 Financial Results Driven By Strong Operational Performance

Cardlytics, Inc. (NASDAQ: CDLX), a purchase intelligence platform, today announced financial results for the second quarter ended June 30, 2026. "The second quarter shows that our execution is translating directly into results. We were within our guidance across all key metrics, with margins...

Cardlytics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Cardlytics, Inc. (NASDAQ: CDLX) today announced that on July 29, 2026, the Compensation Committee of Cardlytics Board of Directors granted an aggregate of 10,320 restricted stock units of Cardlytics to 10 newly hired employees. The restricted stock units were granted as material inducements to...

Cardlytics Appoints Chris Cheng as Chief Legal Officer

Cardlytics Inc. (NASDAQ: CDLX) today announced the appointment of Chris Cheng as Chief Legal Officer, effective August 3, 2026. Cheng will serve on the Leadership Team and oversee Cardlytics Legal and Compliance organization. This press release features multimedia. View the full release here...

Cardlytics to Report Second Quarter 2026 Results on August 5

Cardlytics, Inc. (NASDAQ: CDLX) today announced that its financial results for the second quarter ending June 30, 2026 will be released on August 5, 2026, after market close. Conference Call Details: When: August 5, 2026 at 5:00 pm Eastern time / 2:00 pm Pacific time Webcast: Attendees may access...

Lake Street Cuts Cardlytics, Inc. (CDLX) Price Target to $1.25 Amid Reset Expectations

Lake Street Cuts Cardlytics, Inc. (CDLX) Price Target to $1.25 Amid Reset Expectations...

Cardlytics (CDLX) Q1 2026 Earnings Transcript

@media (max-width: 768px) {
 .image-container {
 width: 100% !important;
 float: none !important;
 margin: 0 0 1rem 0 !important;
 }
 }

Image source: The Mo...

Cardlytics First Quarter 2026 Financial Results Driven By Strong Operational Performance

Cardlytics, Inc. (NASDAQ: CDLX), a commerce media platform, today announced financial results for the first quarter ended March 31, 2026. 'The first quarter of 2026 marks a definitive shift from...

Cardlytics, Inc. (NASDAQ: CDLX) today announced that on April 29, 2026, the Compensation Committee of Cardlytics Board of Directors granted an aggregate of 272,000 restricted stock units of...

Cardlytics (NASDAQ:CDLX) Shares Down 3.1% - Here's Why

Cardlytics (NASDAQ:CDLX) Stock Price Down 3.1% - Here's What Happened...

Cardlytics Announces Timing of Its First Quarter 2026 Earnings Release

Cardlytics, Inc. (NASDAQ: CDLX) today announced that its financial results for the first quarter ending March 31, 2026 will be released on May 7, 2026, after market close. Conference Call Details...

Cardlytics, Inc. engages in the business of operating an advertising platform which includes online, mobile applications, email, and various real-time notifications. It operates through the Cardlytics Platform and Bridg Platform segments. The Cardlytics Platform segment focuses on the United States and the United Kingdom, which represents proprietary advertising channels. The Bridg Platform segment is involved in utilizing POS data from merchant data partners, including product-level purchase data to enable marketers to perform analytics and targeted loyalty marketing in a privacy protected manner. The company was founded by Scott David Grimes, Lynne Marie Laube, and Hans Theisen on June 26, 2008 and is headquartered in Atlanta, GA.

Cardlytics Inc

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Fiscal Period	Estimated	Reported	Surprise	Result
Q3 '26	-$2.02	--	--	N/A
Q2 '26	-$2.30	-$2.58	-12.17%	MISSED
Q1 '26	-$0.37	-$0.80	-116.22%	MISSED
Q4 '25	-$0.21	-$0.15	27.42%	BEAT
Q3 '25	-$0.33	-$1.36	-316.33%	MISSED

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q2 '26

Historical Earnings